CNSX:MARI

Maricann Group (MARI) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
682,578 shs
Average Volume
142,686 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.25
MARI stock logo

About Maricann Group Stock (CNSX:MARI)

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company's services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.

MARI Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Cannabinoids Global Market Report 2023
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
How much cash should investors be holding? Experts weigh in
Wayland Group Corp (WAYL)
See More Headlines
Receive MARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maricann Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.25
High Stock Price Target
$6.50
Low Stock Price Target
$6.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Paul Pathak (Age 49)
    Interim Chairman of the Board
  • Michael B. Stein
    President, Director
  • Ben Ward
    Chief Executive Officer, Interim Chief Financial Officer
  • Geoff Kosar
    Vice President - Sales and Marketing

MARI Stock Analysis - Frequently Asked Questions

Should I buy or sell Maricann Group stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maricann Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MARI shares.
View MARI analyst ratings
or view top-rated stocks.

What is Maricann Group's stock price target for 2024?

1 equities research analysts have issued 12-month price targets for Maricann Group's shares. Their MARI share price targets range from $6.00 to $6.50. On average, they predict the company's share price to reach $6.25 in the next year.
View analysts price targets for MARI
or view top-rated stocks among Wall Street analysts.

What other stocks do shareholders of Maricann Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maricann Group investors own include Aurora Cannabis (ACB), VIVO Cannabis (ABCN), Aphria (APHA), Suncor Energy (SU), Suncor Energy (SU), CV Sciences (CVSI), Canopy Growth (WEED), Barkerville Gold Mines Ltd. (BGM.V) (BGM), Cronos Group (CRON) and Emerald Health Therapeutics (EMH).

How do I buy shares of Maricann Group?

Shares of MARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:MARI) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners